Theramex, a London, UK-based specialty pharma company focusing on women's health, is changing hands in a deal reportedly ...

Businesses are finding that AI is a great leveller. Organisations with mature digital infrastructures can use AI to unlock ...

As an oncologist with more than 25 years of experience across clinical care, research, drug and device development, and ...

Novo has raised its financial guidance for 2026 on the back of rising sales of its oral weight-loss therapy Wegovy, which ...

The BioInnovation Institute (BII) has expanded a network striving to develop treatments for cardiometabolic diseases and ...

Hard on the heels of a £1 billion investment package by pharma companies in last week's UK Budget, AbbVie has pledged another ...

Boehringer Ingelheim is paying $358 million upfront to claim options on up to six antibody-drug conjugates (ADCs) and T cell ...

Bayer's pharma unit has reached a "turning point" in its growth trajectory as sales of new medicines rose 6.4% in the third ...

The WuXi agreement gives Fresenius "full strategic flexibility" to choose which biosimilar candidates to develop and gives ...

Dren Bio has closed a sizeable private financing round, raising $350 million to fund pivotal trials of its potentially ...

Dojolvi was approved in the US in 2020 and was also launched in Japan earlier this year. Ultragenyx recorded sales of $45 ...

The US federal government has awarded $99 million in funding for a one-shot vaccine against the Bundibugyo virus (BDBV), the ...